A sample preservation solution for pet pathogen detection, its preparation method and application

By using a preservation solution composed of guanidine isothiocyanate, sodium chloride, Tris-HCl, and EDTA, the problem of easy degradation of nucleic acids in pet pathogen detection samples at room temperature was solved, achieving long-term stable preservation of various pet samples and ensuring the accuracy of detection results.

CN123108117APending Publication Date: 2026-11-17NANJING ZHUOYI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611536796.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-30
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing technologies for pet pathogen detection, nucleic acids are easily degraded and microorganisms proliferate during room temperature transportation, leading to decreased detection sensitivity and inaccurate quantitative results. Furthermore, existing preservation methods are costly or lack adaptability.

Method used

The preservation solution, composed of guanidine isothiocyanate, sodium chloride, Tris-HCl and EDTA, is simple in formulation and low in cost. It can stably preserve pathogenic nucleic acids in pet samples for a long time at room temperature, inhibit nuclease activity and maintain the relative abundance of microorganisms.

Benefits of technology

It enables stable preservation of pathogenic nucleic acids in pet samples at room temperature for 180 days, ensuring the accuracy and reliability of test results. It is applicable to various sample types and pathogens and is compatible with common nucleic acid extraction and detection methods.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

This invention discloses a sample preservation solution for pet pathogen detection, its preparation method, and its application, belonging to the field of biodetection technology. Each liter of the preservation solution contains: guanidine isothiocyanate, sodium chloride, Tris-HCl buffer, EDTA, and the remainder is deionized water. This invention utilizes the synergistic effect of high-concentration guanidine isothiocyanate to rapidly inactivate nucleases, EDTA to chelate metal ion cofactors, and high-concentration sodium chloride to stabilize nucleic acids and inhibit microbial proliferation. This allows for the long-term stable preservation of nucleic acids from various pathogens, including viruses, bacteria, and parasites, in pet feces and respiratory swabs at room temperature for at least 180 days, with the Ct value range at different time points during preservation not exceeding 1.53. This invention features a simple formulation, low cost, good stability, and wide applicability, making it suitable for long-distance transportation and long-term storage of pet clinical samples, and possesses promising application prospects and market value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of biological detection technology, specifically to a sample preservation solution for pet pathogen detection, its preparation method, and its application. Background Technology

[0002] With the rapid development of the pet medical industry, molecular biological detection of pet pathogens (such as PCR, qPCR, mNGS, etc.) has become an important means of diagnosing pet diseases. Common infectious diseases in pets involve a variety of pathogens, including viruses (such as feline panleukopenia virus, feline herpesvirus, canine parvovirus, canine parainfluenza virus, etc.), bacteria (such as Salmonella, Staphylococcus aureus, Bordetella bronchiseptica, Escherichia coli, etc.), and parasites (such as Giardia lamblia, coccidia, Toxoplasma gondii, etc.). Accurate pathogen detection depends on high-quality sample nucleic acids, and the transportation and storage conditions of samples from collection to testing directly affect the integrity of nucleic acids and the reliability of test results.

[0003] Currently, there is often a time lag and spatial distance between the collection of pet clinical samples and laboratory testing. During the transportation of fecal samples and respiratory swab samples at room temperature, on the one hand, nucleases (such as DNase and RNase) in the samples rapidly degrade pathogen nucleic acids, leading to decreased detection sensitivity or even false negatives; on the other hand, the large number of symbiotic microorganisms present in the samples continue to proliferate at suitable temperatures, altering the relative abundance of pathogen microorganisms and affecting the accuracy of quantitative detection results. In addition, fecal samples contain a large number of PCR inhibitors (such as bile salts, polysaccharides, and heme), and if not stored properly, the release and accumulation of these inhibitors can further interfere with subsequent nucleic acid amplification reactions.

[0004] In the existing technology, the sample preservation schemes mainly include the following: (1) Low temperature cold chain transportation: dry ice or ice packs are used to maintain low temperature. Although they can protect nucleic acid well, the transportation cost is high, the operation is complicated, and it is difficult to guarantee the whole cold chain in long-distance transportation or primary clinic conditions; (2) Commercial nucleic acid preservation solution: some commercial products can stabilize nucleic acid at room temperature, but they are mostly designed for human clinical samples or specific pathogens. They are not suitable for complex inhibitory factors and diverse pathogen types in pet samples, and the price is high; (3) Physiological saline or PBS buffer: can only maintain the basic osmotic pressure of the sample, cannot inhibit nuclease activity, and nucleic acid begins to degrade significantly within a few hours at room temperature.

[0005] Therefore, there is an urgent need in this field to develop a preservation solution that is simple in formulation, low in cost, and can stably preserve the nucleic acids of various pathogens (viruses, bacteria, parasites) in various types of pet samples (feces, respiratory swabs, etc.) for a long time at room temperature, so as to meet the actual needs of sample transportation and preservation in pet medical testing. Summary of the Invention

[0006] The purpose of this invention is to overcome the shortcomings of existing technologies and provide a sample preservation solution for pet pathogen detection, its preparation method, and its application. This preservation solution has a simple formulation, good stability, and low cost. It can stably preserve the nucleic acids of various pathogens such as viruses, bacteria, and parasites in pet feces, respiratory swabs, and other samples for a long period (at least 180 days) at room temperature (15℃~25℃), effectively inhibiting nuclease activity, preventing nucleic acid degradation, and ensuring the accuracy and reliability of subsequent molecular detection results.

[0007] To achieve the above objectives, the present invention adopts the following technical solution:

[0008] A sample preservation solution for pet pathogen detection, each liter of the preservation solution contains the following components:

[0009] Guanidine isothiocyanate (GITC): 3 mol–5 mol; Sodium chloride (NaCl): 150 g–250 g; Tris-HCl buffer: 50 mmol–150 mmol, pH 6.5–7.5; Ethylenediaminetetraacetic acid (EDTA): 10 mmol–30 mmol, pH 7.5–8.5; Balance: deionized water.

[0010] Preferably, each liter of the preservation solution contains the following components:

[0011] Guanidine isothiocyanate: 4 mol; Sodium chloride: 200 g (i.e., 20%, w / v); Tris-HCl buffer: 100 mmol, pH 7.0; EDTA: 20 mmol, pH 8.0; the remainder is deionized water.

[0012] Furthermore, the preservation solution may also contain 0.01% to 0.1% (w / v) of an antibacterial agent, wherein the antibacterial agent is selected from one or more of sodium azide (NaN3), Proclin 300, and thimerosal. Adding an antibacterial agent can further inhibit the proliferation of microorganisms in the sample and extend the shelf life of the preservation solution.

[0013] The present invention also provides a method for preparing the above-mentioned sample preservation solution, comprising the following steps:

[0014] (1) Take about 70% of the total volume of deionized water, add Tris-HCl and EDTA, and stir until completely dissolved;

[0015] (2) Add sodium chloride to the above solution and stir until completely dissolved;

[0016] (3) Add guanidine isothiocyanate to the above solution and stir at room temperature in the dark until completely dissolved;

[0017] (4) Adjust the pH to 6.5–7.5 with hydrochloric acid or sodium hydroxide;

[0018] (5) Make up to the target volume with deionized water, filter through a 0.22μm filter membrane for sterilization, dispense into smaller containers, and store at room temperature away from light for later use.

[0019] This invention also provides the application of the above-mentioned sample preservation solution in the detection of pathogens in pets. The pets include, but are not limited to, cats, dogs, rabbits, and rodents. The sample types include, but are not limited to, fecal samples, respiratory swabs (nasopharyngeal swabs, oropharyngeal swabs), anal swabs, urine, saliva, blood, and tissue homogenates. The pathogens include, but are not limited to, viruses (such as feline calicivirus, feline herpesvirus, canine parvovirus, canine parainfluenza virus, canine adenovirus, feline coronavirus, etc.), bacteria (such as Salmonella, Staphylococcus aureus, Bordetella bronchiseptica, Escherichia coli, Campylobacter, Clostridium perfringens, etc.), and parasites (such as Giardia lamblia, Isospora, Cryptosporidium, Babesia, Toxoplasma gondii, etc.).

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] (1) Broad-spectrum preservation capability: The preservation solution of the present invention can effectively preserve the nucleic acids of multiple types of pathogens such as viruses, bacteria, and parasites at the same time, which is suitable for the needs of joint detection of multiple pathogens in pets, without the need to use different preservation solutions for different pathogens.

[0022] (2) Long-term room temperature preservation period: The preservation solution of the present invention can stably preserve the pathogenic nucleic acid in the sample for at least 180 days at room temperature (15℃~25℃). The Ct value detected at each time point within 1 day to 180 days does not exceed 1.55. The degree of nucleic acid degradation is extremely low, which fully meets the needs of long-distance transportation and long-term storage of samples.

[0023] (3) Simple formula and low cost: This invention contains only four core components (guanidine isothiocyanate, sodium chloride, Tris-HCl, EDTA), all of which are conventional biochemical reagents, easy to obtain, and have a simple preparation process, making them suitable for large-scale production and grassroots promotion.

[0024] (4) Strong nuclease inhibition ability: High concentration of guanidine isothiocyanate (3M~5M) is a strong protein denaturant that can rapidly inactivate DNase and RNase in the sample and prevent nucleic acid degradation from the source; EDTA is a metal ion chelating agent that can chelate nuclease cofactors such as Mg²⁺ and Ca²⁺ and further inhibit nuclease activity.

[0025] (5) High salt environment stabilizes nucleic acid: 15% to 25% sodium chloride provides a high ionic strength environment, which can promote the binding of nucleic acid to silicon-based materials (facilitating subsequent magnetic bead or column extraction). At the same time, the high salt environment can inhibit the proliferation of microorganisms and maintain the relative abundance of pathogenic microorganisms in the sample.

[0026] (6) Good compatibility: The preservation solution of the present invention has good compatibility with common nucleic acid extraction methods (magnetic bead method, column extraction method, phenol-chloroform method) and downstream detection platforms (qPCR, digital PCR, mNGS, etc.), and does not affect the subsequent nucleic acid extraction efficiency and amplification efficiency.

[0027] (7) Wide range of applicable sample types: It is not only suitable for fecal samples, but also for various sample types such as respiratory swabs, anal swabs, saliva, and urine, which can meet the sample preservation needs for pathogen detection in different parts of pets. Detailed Implementation

[0028] The present invention will be further described in detail below with reference to specific embodiments. These embodiments are for illustrative purposes only and are not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

[0029] Experimental methods not specified in the examples are generally performed under standard conditions or as recommended by the manufacturer. All reagents and instruments used are commercially available, standard products.

[0030] Example 1: Preparation of sample preservation solution

[0031] Prepare 1L of the sample preservation solution of the present invention according to the following formulation (preferred formulation):

[0032] Guanidine isothiocyanate: 4 mol (472.6 g); Sodium chloride: 200 g (20%, w / v); Tris-HCl: 100 mmol (pH 7.0, provided by 1 M Tris-HCl stock solution); EDTA: 20 mmol (pH 8.0, provided by 0.2 M EDTA stock solution); Deionized water: bring to a final volume of 1000 mL.

[0033] The preparation steps are as follows:

[0034] (1) Take 700 mL of deionized water and place it in a clean beaker. Add 100 mL of 1 M Tris-HCl (pH 7.0) and 100 mL of 0.2 M EDTA (pH 8.0) and stir magnetically until evenly mixed.

[0035] (2) Add 200g of sodium chloride to the above solution and continue stirring until completely dissolved;

[0036] (3) Add 472.6g of guanidine isothiocyanate to the above solution in batches, and stir magnetically at room temperature in the dark for about 30 minutes until completely dissolved;

[0037] (4) Adjust the pH of the solution to 7.0 ± 0.1 using 1M hydrochloric acid or 1M sodium hydroxide;

[0038] (5) Make up to 1000 mL with deionized water, filter through a 0.22 μm sterile filter membrane for sterilization, dispense 40 mL into 50 mL sterile centrifuge tubes, and store at room temperature away from light for later use.

[0039] The preservation solution prepared by the above method is a colorless and transparent liquid with a pH of 7.0 ± 0.2, and can be stably stored at room temperature for at least 24 months.

[0040] Example 2: Verification of the long-term preservation effect of pathogenic nucleic acid in respiratory samples

[0041] This embodiment verifies the long-term preservation effect of the preservation solution of the present invention on viral and bacterial nucleic acids in respiratory swab samples.

[0042] 1. Experimental materials:

[0043] (1) Preservation solution: The sample preservation solution prepared in Example 1;

[0044] (2) Samples: Three nasopharyngeal swab samples were collected from cats clinically diagnosed with feline herpesvirus type 1 (FHV-1) and Bordetellabronchiseptica. The samples of the same type were thoroughly mixed and used as experimental samples.

[0045] (3) Control: Sterile physiological saline (0.9% NaCl) was used as the control preservation solution;

[0046] (4) Detection method: Nucleic acid was extracted by magnetic bead method, and real-time fluorescence quantitative PCR (qPCR) was used to detect FHV-1 gB gene and Bordetella bronchiseptica 16S rRNA gene. Each sample was tested three times and the average Ct value was taken.

[0047] 2. Experimental Methods:

[0048] Each mixed nasopharyngeal swab sample was immersed in an equal volume of the preservation solution of this invention and physiological saline, vortexed thoroughly, and then stored in a 25°C incubator in the dark. Samples were taken on days 1, 7, 30, 90, and 180 of storage, nucleic acids were extracted, and qPCR was performed. The Ct values ​​at each time point were recorded. Three biological replicates were set up for each time point.

[0049] 3. Experimental Results:

[0050] Table 1 below shows the Ct values ​​of two pathogens in respiratory samples after being stored at room temperature for different times in the preservation solution of this invention for qPCR detection.

[0051] Table 1. Record of Ct values ​​of pathogens in respiratory samples stored at room temperature for different durations. Detecting pathogens Day 1 Day 7 Day 30 Day 90 Day 180 Feline herpesvirus type 1 28.45±0.12 28.75±0.15 29.10±0.18 29.55±0.22 29.90±0.25 Bordetella bronchiseptica 26.75±0.10 27.00±0.13 27.30±0.16 27.70±0.19 28.03±0.22

[0052] As shown in Table 1 above, in the preservation solution of the present invention, the Ct values ​​of feline herpesvirus type 1 and Bordetella bronchiseptica nucleic acid increased by 1.45 and 1.28 respectively after being stored at room temperature for 180 days, with a maximum range of 1.45. All values ​​were controlled within 1.5, indicating that the pathogen nucleic acid maintained good stability during storage and did not undergo significant degradation.

[0053] As a control, in the saline group, the Ct value of FHV-1 had increased to over 35.2 on day 7 (an increase of approximately 6.8 from day 1), and the Ct value of Bordetella bronchiseptica had increased to over 32.6 (an increase of approximately 5.9 from day 1); by day 30, neither pathogen was detectable (Ct value > 40 or no amplification curve). This fully demonstrates that the preservation solution of this invention has excellent long-term protective effect against pathogen nucleic acids in respiratory samples.

[0054] Example 3: Verification of the long-term preservation effect of pathogenic nucleic acid in digestive tract (feces) samples

[0055] This embodiment verifies the long-term preservation effect of the preservation solution of the present invention on the nucleic acids of viruses, parasites and bacteria in fecal samples.

[0056] 1. Experimental materials:

[0057] (1) Preservation solution: The sample preservation solution prepared in Example 1;

[0058] (2) Samples: Collect fecal samples from clinically diagnosed cats, including three samples each of feline panleukopenia virus (FPV), Giardial amblycemia, and Staphylococcus aureus. Mix the samples of the same type thoroughly and use them as experimental samples.

[0059] (3) Control: Sterile physiological saline was used as the control preservation solution;

[0060] (4) Detection method: Nucleic acid was extracted by magnetic bead method, and qPCR was used to detect FPV VP2 gene, Giardia lamblia bg gene and Staphylococcus aureus nuc gene respectively. Each sample was tested 3 times and the average Ct value was taken.

[0061] 2. Experimental Methods:

[0062] Weigh 200 μL of each well-mixed fecal sample and add 1 mL of the preservation solution of this invention or physiological saline. Vortex thoroughly to mix and then store in a 25°C incubator protected from light. Samples were taken on days 1, 7, 30, 90, and 180 of storage, nucleic acids were extracted, and qPCR was performed. The Ct values ​​at each time point were recorded. Three biological replicates were set up for each time point.

[0063] 3. Experimental Results:

[0064] Table 2 below shows the Ct values ​​of the three pathogens in fecal samples after different storage times at room temperature in the preservation solution of this invention for qPCR detection:

[0065] Table 2. Record of Ct values ​​of pathogens in fecal samples stored at room temperature for different durations. Detecting pathogens Day 1 Day 7 Day 30 Day 90 Day 180 Feline panleukopenia virus 30.18±0.14 30.50±0.17 30.90±0.20 31.35±0.24 31.69±0.26 Giardia lamblia 29.55±0.12 29.82±0.15 30.15±0.18 30.60±0.21 30.90±0.24 Staphylococcus aureus 27.28±0.11 27.50±0.14 27.78±0.17 28.15±0.20 28.46±0.23

[0066] As shown in Table 2 above, in the preservation solution of this invention, the Ct values ​​of fecal panleukopenia virus, Giardia lamblia and Staphylococcus aureus nucleic acids in fecal samples increased by 1.51, 1.35 and 1.18 respectively after being stored at room temperature for 180 days, with a maximum range of 1.51, indicating that the nucleic acids of the three different types of pathogens maintained good stability during the preservation period.

[0067] It is worth noting that fecal samples contain a large number of nucleases and PCR inhibitors, which places higher demands on the protective ability of the preservation solution. The high concentration of guanidine isothiocyanate in the preservation solution of this invention can rapidly inactivate nucleases in feces, and the high concentration of sodium chloride can effectively precipitate some inhibitors, thereby achieving long-term stable preservation of nucleic acids of multiple pathogens in fecal samples.

[0068] As a control, in the saline group, the Ct value of FPV had increased to over 38.5 by day 7 (an increase of approximately 8.3 from day 1), and the Ct values ​​of Giardia lamblia and Staphylococcus aureus had increased to over 37.2 and 34.8, respectively; by day 30, all three pathogens were undetectable. This further verifies the excellent protective effect of the preservation solution of this invention on pathogen nucleic acids in complex fecal samples.

[0069] Example 4: Verification of storage stability under different temperature conditions

[0070] This embodiment verifies the preservation effect of the preservation solution of the present invention on pathogen nucleic acid under different temperature conditions.

[0071] 1. Experimental Methods:

[0072] Five pathogen-positive samples (FHV-1, Bordetella bronchiseptica, FPV, Giardia lamblia, and Staphylococcus aureus) used in Examples 2 and 3 were added to the preservation solution of this invention and stored at 4°C, 25°C, and 37°C, respectively, in the dark. Samples were taken on day 1 and day 180 of storage, nucleic acids were extracted and qPCR was performed, and the change in Ct value was calculated (ΔCt = Ct value on day 180 - Ct value on day 1).

[0073] 2. Experimental Results:

[0074] The changes in Ct values ​​of various pathogens after 180 days of storage under different temperature conditions are shown in Table 3 below:

[0075] Table 3. Record of Ct values ​​of pathogens stored for 180 days under different temperature conditions. Detecting pathogens 4℃ 25℃ 60℃ Feline herpesvirus type 1 0.68 1.31 1.45 Bordetella bronchiseptica 0.58 1.04 1.28 Feline panleukopenia virus 0.72 1.28 1.53 Giardia lamblia 0.65 1.21 1.35 Staphylococcus aureus 0.55 1.18 1.29

[0076] As shown in Table 3 above, after 180 days of storage at 4℃, the ΔCt of all pathogens was less than 0.8, indicating excellent nucleic acid stability. After 180 days of storage at room temperature (25℃), the ΔCt of all pathogens did not exceed 1.31, maintaining good nucleic acid stability. Even after 180 days of storage at high temperature (60℃), the ΔCt of all pathogens was still less than 1.53, indicating that the preservation solution of this invention has good nucleic acid protection ability over a wide temperature range and can meet the needs of different transportation and storage environments.

Claims

1. A sample preservation solution for pet pathogen detection, characterized in that, Each liter of the preservation solution contains the following components: guanidine isothiocyanate 3 mol to 5 mol, sodium chloride 150 g to 250 g, Tris-HCl buffer 50 mmol to 150 mmol with pH 6.5 to 7.5, EDTA 10 mmol to 30 mmol with pH 7.5 to 8.5, and the balance being deionized water.

2. The sample preservation solution according to claim 1, characterized in that, Each liter of the preservation solution contains the following components: 4 mol guanidine isothiocyanate, 200 g sodium chloride, 100 mmol Tris-HCl buffer at pH 7.0, 20 mmol EDTA at pH 8.0, and the remainder is deionized water.

3. The sample preservation solution according to claim 1, characterized in that, The preservation solution also contains 0.01% to 0.1% (w / v) of an antibacterial agent selected from one or more of sodium azide, ProClin 300, and thimerosal.

4. A method for preparing a sample preservation solution as described in any one of claims 1 to 3, characterized in that, The steps include: (1) Take about 70% of the total volume of deionized water, add Tris-HCl and EDTA, and stir until completely dissolved; (2) Add sodium chloride to the above solution and stir until completely dissolved; (3) Add guanidine isothiocyanate to the above solution and stir at room temperature in the dark until completely dissolved; (4) Adjust the pH to 6.5 to 7.5; (5) Make up to the target volume with deionized water, filter to remove bacteria, and dispense.

5. The preparation method according to claim 4, characterized in that, The filtration and sterilization process in step (5) uses a 0.22 μm filter membrane.

6. The application of the sample preservation solution as described in any one of claims 1 to 3 in the detection of pet pathogens.

7. The application according to claim 6, characterized in that, The pets include cats, dogs, rabbits, and rodents.

8. The application according to claim 6, characterized in that, The sample types include one or more of the following: fecal samples, respiratory swabs, anal swabs, urine, saliva, blood, and tissue homogenates.

9. The application according to claim 6, characterized in that, The pathogens include one or more of viruses, bacteria, and parasites.

10. The application according to claim 9, characterized in that, The viruses include one or more of feline panleukopenia virus, feline herpesvirus, canine parvovirus, canine parainfluenza virus, feline calicivirus, and feline coronavirus; the bacteria include one or more of Salmonella, Staphylococcus aureus, Bordetella bronchiseptica, Escherichia coli, Campylobacter, and Clostridium; and the parasites include one or more of Giardia lamblia, Isospora, Cryptosporidium, Babesia, and Toxoplasma gondii.

11. The application according to claim 6, characterized in that, The sample preservation solution can stably preserve pathogenic nucleic acids in the sample for at least 180 days at 15℃~25℃, and the range of CT values ​​for pathogenic nucleic acid detection during the preservation period does not exceed 1.53.